Hanzel J, Kozelj M, Spes Hlastec A, Kurent T, et al. Ustekinumab concentrations shortly after escalation to monthly dosing may identify endoscopic remission in refractory Crohn's disease. Eur J Gastroenterol Hepatol 2021;33.
PMID: 34402470